203
Participants
Start Date
July 14, 2021
Primary Completion Date
September 4, 2024
Study Completion Date
January 31, 2026
ReActiv8
Market-approved ReActiv8 device implanted
Ainsworth Institute of Pain Management, New York
Northwell Health, Great Neck
Center for Interventional Pain and Spine, Lancaster
International Spine, Pain and Performance Center, Washington D.C.
The Center for Clinical Research, LLC, Winston-Salem
Duke University, Durham
OrthoCarolina Sports Medicine Center, Charlotte
Horizon Clinical Research, Fayetteville
Vista Clinical Research, Newnan
Augusta Orthopedic & Sports Medicine Specialists, Augusta
Cantor Spine Center and Paley Orthopedic Spine Institute, West Palm Beach
Cleveland Clinic Martin Health Tradition Hospital, Port Saint Lucie
University Hospitals Cleveland, Cleveland
Cleveland Clinic, Cleveland
Indiana Spine Group, Carmel
OrthoIndy, Indianapolis
Freeman Hospital, Joplin
SSM Health Medical Group, Jefferson City
Columbia Orthopedic Group, Columbia
University of Kansas Medical Center, Kansas City
Advent Health Shawnee Mission, Shawnee Mission
University of Arkansas for Medical Sciences, Little Rock
University of Colorado, Aurora
Barrow Brain & Spine, Phoenix
SoCal Sport and Spine, Newport Beach
Pacific Research Institute, Santa Rosa
Spinal Diagnostics, PC, Tualatin
Pacific Sports and Spine, Eugene
Lead Sponsor
Mainstay Medical
INDUSTRY